These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5262170)

  • 1. Pulmonary function studies in systemic sclerosis (scleroderma).
    Haddad RG; Rotsztain A; Canter HG
    Med Ann Dist Columbia; 1970 Jan; 39(1):14-6. PubMed ID: 5262170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary function in scleroderma].
    Romeiro Neto M; Barbas Filho JV; Vargas FS; Varrastro C; Cukier A; Onishi R; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1980 Aug; 35(4):178-82. PubMed ID: 7455500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sclerodermic pneumofibrosis (clinical-functional characteristics)].
    Guseva NG; Falomeeva OM; Sysoev VF; Mach ES
    Ter Arkh; 1969 Mar; 41(3):36-41. PubMed ID: 5358782
    [No Abstract]   [Full Text] [Related]  

  • 4. [Respiratory function profile in scleroderma. 20 cases (author's transl)].
    Kleisbauer JP; Feliciano JM; Colonna J; Velardocchio JM; Laval P
    Poumon Coeur; 1980; 36(6):371-6. PubMed ID: 7220421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Longitudinal study of parameters of respiratory function tests and blood gas analysis in patients with progressive systemic scleroderma].
    Georgiev O; Shoshkov P; Rashkov R
    Vutr Boles; 2001; 33(2-3):37-40. PubMed ID: 12001574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary manifestations of scleroderma].
    König G; O'Sullivan C; Luderschmidt C; Scherer U; Albrecht J; Fruhmann G
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():784-6. PubMed ID: 6647334
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
    Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
    J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between occupational risk factors and severity markers of systemic sclerosis.
    Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
    J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of pulmonary arterial hypertension in scleroderma.
    Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
    Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Total pulmonary volume and residual air in scleroderma and systemic lupus erythematosus patients].
    Balabaeva PN
    Ter Arkh; 1968 Nov; 40(11):79-81. PubMed ID: 5746749
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between serum immunoglobulin levels and pulmonary involvement in systemic sclerosis.
    Yuhara T; Takemura H; Akama T; Yamane K; Sumida T
    J Rheumatol; 2000 May; 27(5):1207-14. PubMed ID: 10813289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
    Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE
    Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [External respiratory functions in systemic scleroderma].
    Drampian FS; Manukian DzhA ; Topchian AS; Danilova LL; Azizian AL
    Zh Eksp Klin Med; 1975; 15(2):87-90. PubMed ID: 1136647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aspects of respiratory mechanics in some pararheumatic diseases].
    Gatto E; Canepa F; Battaglia A; Gatto PL; Carli G; Cavallo F
    Arch Maragliano Patol Clin; 1966; 22(6):655-61. PubMed ID: 6014946
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static lung mechanics in patients of progressive systemic sclerosis without obvious pulmonary involvement.
    Gupta D; Aggarwal AN; Sud A; Jindal SK
    Indian J Chest Dis Allied Sci; 2001; 43(2):97-101. PubMed ID: 11529415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for pulmonary arterial hypertension in systemic sclerosis.
    Busteed S; Moots RJ; Thompson RN
    Rheumatology (Oxford); 2004 Oct; 43(10):1315-6; author reply 1316. PubMed ID: 15448224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.